425256004: Product containing ranibizumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing angiogenesis inhibitor\Product containing ranibizumab

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing ranibizumab

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

2641603013 Ranibizumab (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
2645709013 Ranibizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3523203019 Product containing ranibizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3523204013 Product containing ranibizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3668541010 Ranibizumab product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3716427010 Ranibizumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107865901000001116 Ranibizumab en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing ranibizumab	Is a	Product containing angiogenesis inhibitor	true	Inferred relationship	Existential restriction modifier
Product containing ranibizumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Product containing ranibizumab	Has active ingredient	Ranibizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing ranibizumab	Is a	Drugs used in the eye	false	Inferred relationship	Existential restriction modifier
Product containing ranibizumab	Has manufactured dose form	Ocular dose form	false	Inferred relationship	Existential restriction modifier
Product containing ranibizumab	Is a	Product manufactured as ocular dose form	false	Inferred relationship	Existential restriction modifier
Product containing ranibizumab	Has active ingredient	Substance with angiogenesis inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier
Product containing ranibizumab	Is a	Virtual therapeutic moiety	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial	Is a	False	Product containing ranibizumab	Inferred relationship	Existential restriction modifier
Ranibizumab	Is a	True	Product containing ranibizumab	Inferred relationship	Existential restriction modifier
Product containing ranibizumab in parenteral dose form (medicinal product form)	Is a	True	Product containing ranibizumab	Inferred relationship	Existential restriction modifier
Ranibizumab 3mg/0.3ml solution for injection vials	Is a	False	Product containing ranibizumab	Inferred relationship	Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials	Is a	False	Product containing ranibizumab	Inferred relationship	Existential restriction modifier
Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes	Is a	False	Product containing ranibizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets